• Nenhum resultado encontrado

Luiz Henrique Araujo 1,2,a

N/A
N/A
Protected

Academic year: 2019

Share "Luiz Henrique Araujo 1,2,a"

Copied!
10
0
0

Texto

Loading

Imagem

Figure 2. Crude and age-adjusted lung cancer mortality rates by gender. Brazil, 1980-2007
Table 1. Lung cancer distribution by histology and staging.
Table 2. Frequency of EGFR mutations and clinical characteristics in Brazilian cohorts.
Table 3. Summary of the most relevant studies on non-small cell lung cancer palliative systemic treatment in Brazil.

Referências

Documentos relacionados

Prognostic significance of metastases to mediastinal lymph node levels in resected non small cell lung carcinoma.. Surgery for stage IIIA-N2 non small cell

Survival and prognostic factors in patients with Non-Small Cell Lung Cancer treated in private health care.. Sobrevida e fatores prognósticos em pacientes com câncer de pulmão de

Clinical model to predict survival in chemonaive patients with advanced non-small-cell lung cancer treated with third-generation chemotherapy regimens based on eastern

The objective of the present article was to analyze the importance of social, behavioral, and clinical factors on the survival time of patients with non-small cell lung cancer

The aim of this study is to investigate whether there is a correlation between anemia, other clinic- pathological factors and survival in patients with advanced NSCLC treated

Mutation in the tyrosine kinase domain of epidermal growth factor receptor is a predictive and prognostic factor for gefitinib treatment in patients with non-small cell lung

(2015) Baseline and Trend of Lymphocyte-to-Monocyte Ratio as Prognostic Factors in Epidermal Growth Factor Receptor Mutant Non-Small Cell Lung Cancer Patients Treated with

Quantification of Cell-Free mSHOX2 Plasma DNA for Therapy Monitoring in Advanced Stage Non-Small Cell (NSCLC) and Small-Cell Lung Cancer (SCLC) Patients.. Bernd Schmidt 1 , Julia